Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Inhibitory Interneurons (NRTX-1001) in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)

NCT05135091 is registered in ClinicalTrials.gov with Neurona Therapeutics as lead sponsor.

NCT NCT05135091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05135091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Inhibitory Interneurons (NRTX-1001) in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)
Lead sponsor
Neurona Therapeutics
Phase
Phase 3
Overall status
Recruiting
Start date
June 16, 2022
Completion date
September 30, 2043
Enrollment
88 (estimated)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

mesial temporal lobe epilepsy